Cargando…

Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in Acute Myeloid Leukemia

BACKGROUND: Translocations of the Mixed Lineage Leukemia (MLL) gene occur in a subset (5%) of acute myeloid leukemias (AML), and in mixed phenotype acute leukemias in infancy - a disease with extremely poor prognosis. Animal model systems show that MLL gain of function mutations may contribute to le...

Descripción completa

Detalles Bibliográficos
Autores principales: Röhrs, Sonja, Dirks, Wilhelm G, Meyer, Claus, Marschalek, Rolf, Scherr, Michaela, Slany, Robert, Wallace, Andrew, Drexler, Hans G, Quentmeier, Hilmar
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770485/
https://www.ncbi.nlm.nih.gov/pubmed/19835597
http://dx.doi.org/10.1186/1476-4598-8-86
_version_ 1782173666867412992
author Röhrs, Sonja
Dirks, Wilhelm G
Meyer, Claus
Marschalek, Rolf
Scherr, Michaela
Slany, Robert
Wallace, Andrew
Drexler, Hans G
Quentmeier, Hilmar
author_facet Röhrs, Sonja
Dirks, Wilhelm G
Meyer, Claus
Marschalek, Rolf
Scherr, Michaela
Slany, Robert
Wallace, Andrew
Drexler, Hans G
Quentmeier, Hilmar
author_sort Röhrs, Sonja
collection PubMed
description BACKGROUND: Translocations of the Mixed Lineage Leukemia (MLL) gene occur in a subset (5%) of acute myeloid leukemias (AML), and in mixed phenotype acute leukemias in infancy - a disease with extremely poor prognosis. Animal model systems show that MLL gain of function mutations may contribute to leukemogenesis. Wild-type (wt) MLL possesses histone methyltransferase activity and functions at the level of chromatin organization by affecting the expression of specific target genes. While numerous MLL fusion proteins exert a diverse array of functions, they ultimately serve to induce transcription of specific genes. Hence, acute lymphoblastic leukemias (ALL) with MLL mutations (MLLmu) exhibit characteristic gene expression profiles including high-level expression of HOXA cluster genes. Here, we aimed to relate MLL mutational status and tumor suppressor gene (TSG) methylation/expression in acute leukemia cell lines. RESULTS: Using MS-MLPA (methylation-specific multiplex ligation-dependent probe amplification assay), methylation of 24 different TSG was analyzed in 28 MLLmu and MLLwt acute leukemia cell lines. On average, 1.8/24 TSG were methylated in MLLmu AML cells, while 6.2/24 TSG were methylated in MLLwt AML cells. Hypomethylation and expression of the TSG BEX2, IGSF4 and TIMP3 turned out to be characteristic of MLLmu AML cell lines. MLLwt AML cell lines displayed hypermethylated TSG promoters resulting in transcriptional silencing. Demethylating agents and inhibitors of histone deacetylases restored expression of BEX2, IGSF4 and TIMP3, confirming epigenetic silencing of these genes in MLLwt cells. The positive correlation between MLL translocation, TSG hypomethylation and expression suggested that MLL fusion proteins were responsible for dysregulation of TSG expression in MLLmu cells. This concept was supported by our observation that Bex2 mRNA levels in MLL-ENL transgenic mouse cell lines required expression of the MLL fusion gene. CONCLUSION: These results suggest that the conspicuous expression of the TSG BEX2, IGSF4 and TIMP3 in MLLmu AML cell lines is the consequence of altered epigenetic properties of MLL fusion proteins.
format Text
id pubmed-2770485
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27704852009-10-30 Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in Acute Myeloid Leukemia Röhrs, Sonja Dirks, Wilhelm G Meyer, Claus Marschalek, Rolf Scherr, Michaela Slany, Robert Wallace, Andrew Drexler, Hans G Quentmeier, Hilmar Mol Cancer Research BACKGROUND: Translocations of the Mixed Lineage Leukemia (MLL) gene occur in a subset (5%) of acute myeloid leukemias (AML), and in mixed phenotype acute leukemias in infancy - a disease with extremely poor prognosis. Animal model systems show that MLL gain of function mutations may contribute to leukemogenesis. Wild-type (wt) MLL possesses histone methyltransferase activity and functions at the level of chromatin organization by affecting the expression of specific target genes. While numerous MLL fusion proteins exert a diverse array of functions, they ultimately serve to induce transcription of specific genes. Hence, acute lymphoblastic leukemias (ALL) with MLL mutations (MLLmu) exhibit characteristic gene expression profiles including high-level expression of HOXA cluster genes. Here, we aimed to relate MLL mutational status and tumor suppressor gene (TSG) methylation/expression in acute leukemia cell lines. RESULTS: Using MS-MLPA (methylation-specific multiplex ligation-dependent probe amplification assay), methylation of 24 different TSG was analyzed in 28 MLLmu and MLLwt acute leukemia cell lines. On average, 1.8/24 TSG were methylated in MLLmu AML cells, while 6.2/24 TSG were methylated in MLLwt AML cells. Hypomethylation and expression of the TSG BEX2, IGSF4 and TIMP3 turned out to be characteristic of MLLmu AML cell lines. MLLwt AML cell lines displayed hypermethylated TSG promoters resulting in transcriptional silencing. Demethylating agents and inhibitors of histone deacetylases restored expression of BEX2, IGSF4 and TIMP3, confirming epigenetic silencing of these genes in MLLwt cells. The positive correlation between MLL translocation, TSG hypomethylation and expression suggested that MLL fusion proteins were responsible for dysregulation of TSG expression in MLLmu cells. This concept was supported by our observation that Bex2 mRNA levels in MLL-ENL transgenic mouse cell lines required expression of the MLL fusion gene. CONCLUSION: These results suggest that the conspicuous expression of the TSG BEX2, IGSF4 and TIMP3 in MLLmu AML cell lines is the consequence of altered epigenetic properties of MLL fusion proteins. BioMed Central 2009-10-16 /pmc/articles/PMC2770485/ /pubmed/19835597 http://dx.doi.org/10.1186/1476-4598-8-86 Text en Copyright © 2009 Röhrs et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Röhrs, Sonja
Dirks, Wilhelm G
Meyer, Claus
Marschalek, Rolf
Scherr, Michaela
Slany, Robert
Wallace, Andrew
Drexler, Hans G
Quentmeier, Hilmar
Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in Acute Myeloid Leukemia
title Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in Acute Myeloid Leukemia
title_full Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in Acute Myeloid Leukemia
title_fullStr Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in Acute Myeloid Leukemia
title_full_unstemmed Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in Acute Myeloid Leukemia
title_short Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in Acute Myeloid Leukemia
title_sort hypomethylation and expression of bex2, igsf4 and timp3 indicative of mll translocations in acute myeloid leukemia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770485/
https://www.ncbi.nlm.nih.gov/pubmed/19835597
http://dx.doi.org/10.1186/1476-4598-8-86
work_keys_str_mv AT rohrssonja hypomethylationandexpressionofbex2igsf4andtimp3indicativeofmlltranslocationsinacutemyeloidleukemia
AT dirkswilhelmg hypomethylationandexpressionofbex2igsf4andtimp3indicativeofmlltranslocationsinacutemyeloidleukemia
AT meyerclaus hypomethylationandexpressionofbex2igsf4andtimp3indicativeofmlltranslocationsinacutemyeloidleukemia
AT marschalekrolf hypomethylationandexpressionofbex2igsf4andtimp3indicativeofmlltranslocationsinacutemyeloidleukemia
AT scherrmichaela hypomethylationandexpressionofbex2igsf4andtimp3indicativeofmlltranslocationsinacutemyeloidleukemia
AT slanyrobert hypomethylationandexpressionofbex2igsf4andtimp3indicativeofmlltranslocationsinacutemyeloidleukemia
AT wallaceandrew hypomethylationandexpressionofbex2igsf4andtimp3indicativeofmlltranslocationsinacutemyeloidleukemia
AT drexlerhansg hypomethylationandexpressionofbex2igsf4andtimp3indicativeofmlltranslocationsinacutemyeloidleukemia
AT quentmeierhilmar hypomethylationandexpressionofbex2igsf4andtimp3indicativeofmlltranslocationsinacutemyeloidleukemia